Results 41 to 50 of about 2,224,916 (342)

Biopolymers for Biomedical and Pharmaceutical Applications: Recent Advances and Overview of Alginate Electrospinning

open access: yesNanomaterials, 2019
Innovative solutions using biopolymer-based materials made of several constituents seems to be particularly attractive for packaging in biomedical and pharmaceutical applications.
Jolanta Wróblewska-Krepsztul   +3 more
doaj   +1 more source

Methods of extraction of bioactive compounds from Terminalia Chebula (Haritaki) and their application in food and pharmaceutical industry: A review

open access: yesFood Bioengineering, 2023
Medicinal plants are an integral element of human society's effort to battle illness. Terminalia chebula Retz. (Haritaki) is known in China as the “King of Medicine” and is usually at the top of the list of “Ayurvedic Material Medica” due to its ...
Avinash K. Jha, Nandan Sit
doaj   +1 more source

The Workforce Needs of New Jersey's Pharmaceutical and Medical Technology Industry [PDF]

open access: yes, 2007
This report is based on an online survey conducted in spring 2006 of pharmaceutical and medical technology companies in New Jersey. It identifies the current and future workforce needs of the pharmaceutical and medical technology industry in New ...

core  

Reviewing the Drivers and Challenges in RFID Implementation in the Pharmaceutical Supply Chain [PDF]

open access: yes, 2009
Counterfeiting is a global phenomenon that poses a serious financial threat to the pharmaceutical industry and more importantly jeopardizes public safety and security.
Li, Suhong   +2 more
core   +2 more sources

The anti‐CRISPR protein AcrIE8.1 inhibits the type I‐E CRISPR‐Cas system by directly binding to the Cascade subunit Cas11

open access: yesFEBS Letters, EarlyView.
In this study, we present the structure of AcrIE8.1, a previously uncharacterized anti‐CRISPR protein that inhibits the type I‐E CRISPR‐Cas system. Through a combination of structural and biochemical analyses, we demonstrate that AcrIE8.1 directly binds to the Cas11 subunit of the Cascade complex to inhibit the CRISPR‐Cas system.
Young Woo Kang, Hyun Ho Park
wiley   +1 more source

Geriatric pharmacotherapy : optimisation through integrated approach in the hospital setting [PDF]

open access: yes, 2016
Since older patients are more vulnerable to adverse drug-related events, there is a need to ensure appropriate prescribing in these patients in order to prevent misuse, overuse and underuse of drugs.
A Corsonello   +63 more
core   +1 more source

Function‐driven design of a surrogate interleukin‐2 receptor ligand

open access: yesFEBS Letters, EarlyView.
Interleukin (IL)‐2 signaling can be achieved and precisely fine‐tuned through the affinity, distance, and orientation of the heterodimeric receptors with their ligands. We designed a biased IL‐2 surrogate ligand that selectively promotes effector T and natural killer cell activation and differentiation. Interleukin (IL) receptors play a pivotal role in
Ziwei Tang   +9 more
wiley   +1 more source

Open Data for Research and Strategic Monitoring in the Pharmaceutical and Biotech Industry

open access: yesData Science Journal, 2017
Open data is considered the new oil. As oil can be used to produce fertilisers, pesticides, lubricants, plastics and many other derivatives, so data is considered the commodity to use and re-use to create value.
Baldissera Giovani
doaj   +1 more source

Comparative Study of Pharmaceutical, Herbal Medicine, and Low-Value Alternating Electromagnetic Radiation as Anti-Malaria Treatment

open access: yesIndonesian Journal of Innovation and Applied Sciences, 2023
Malaria is a significant global health burden, particularly in regions with limited healthcare resources. Pharmaceutical interventions, specifically artemisinin-based combination therapies (ACTs), have long been the mainstay of malaria treatment due to ...
Abayomi Alade
doaj   +1 more source

After Heparin: Protecting Consumers From the Risks of Substandard and Counterfeit Drugs [PDF]

open access: yes, 2011
Based on case studies, examines globalization and quality management trends in pharmaceutical manufacturing, barriers to Federal Drug Administration oversight, and the security of pharmaceutical distribution.

core  

Home - About - Disclaimer - Privacy